Inventor · disambiguated record
Thomas Sciascia
Also filed as: SCIASCIA THOMAS
13 granted patents·20 pending applications·45 citations·filing 2004–2025
90Inventor score
Files withTREVI THERAPEUTICS INC22ENDO PHARMACEUTICALS INC5PENWEST PHARMACEUTICALS CO3BAICHWAL ANAND R2Trevi Therapeutics1
Top patents by PatentIndex Score
33 records- 0191US11660296B2Treatment of chronic cough, breathlessness and dyspneaTREVI THERAPEUTICS INC·Filed 2022·Granted May 30, 2023·1 cites·26 claims
- 0290US8987289B2Methods for treating pruritusTREVI THERAPEUTICS INC·Filed 2013·Granted Mar 24, 2015·9 cites·22 claims
- 0390US8637538B1Methods for treatment of pruritisTrevi Therapeutics·Filed 2012·Granted Jan 28, 2014·13 cites·32 claims
- 0489US8940753B1Methods for treating pruritisTREVI THERAPEUTICS INC·Filed 2014·Granted Jan 27, 2015·5 cites·16 claims
- 0587US8394812B2Sustained release formulations of nalbuphineBAICHWAL ANAND R·Filed 2008·Granted Mar 12, 2013·9 cites·57 claims
- 0686US10238646B2Methods for treating pruritusTREVI THERAPEUTICS INC·Filed 2015·Granted Mar 26, 2019·2 cites·23 claims
- 0785US2024423975A1Treatment of chronic cough, breathlessness and dyspneaTREVI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0884US2025339424A1Treatment of chronic cough, breathlessness and dyspneaTREVI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0983US2025032480A1Methods for treating pruritusTREVI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1078US8771732B2Sustained release formulations of nalbuphineBAICHWAL ANAND R·Filed 2006·Granted Jul 8, 2014·3 cites·24 claims
- 1175US2022409613A1Treatment of chronic cough, breathlessness and dyspneaTREVI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1275US2023338367A1Treatment of prurigo nodularisTREVI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1373US9351938B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2014·Granted May 31, 2016·1 cites·24 claims
- 1472US8765175B2Sustained release formulation of nalbuphinePENWEST PHARMACEUTICALS CO·Filed 2013·Granted Jul 1, 2014·1 cites·37 claims
- 1570US9186330B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·1 cites·37 claims
- 1667US10406106B2Sustained release formulations of nalbuphineENDO PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·0 cites·21 claims
- 1767US2014179727A1Methods for treating pruritusTREVI THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1867US2022347171A1Treatment of prurigo nodularisTREVI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1964US2020022974A1Treatment of chronic cough, breathlessness and dyspneaTREVI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2064US2014350042A1Methods for treating pruritusTREVI THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2163US12274696B2Methods of administering nalbuphineTREVI THERAPEUTICS INC·Filed 2022·Granted Apr 15, 2025·0 cites·30 claims
- 2263US10172798B2Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·0 cites·24 claims
- 2360US2018125840A1Treatment of prurigo nodularisTREVI THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2457US2017000782A1Methods for treating pruritusTREVI THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2557US2016263035A1Sustained release formulation of nalbuphineENDO PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2657US2019099416A1Methods for treating pruritusTREVI THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2753US2025213552A1Methods of administering nalbuphineTREVI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2852US2007196482A1Sustained release torsemide dosage formsPENWEST PHARMACEUTICALS CO·Filed 2006·Application pending·0 cites
- 2950US2015359789A1Methods for treating pruritusTREVI THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3043US2005169991A1Sustained release torsemide dosage formsPENWEST PHARMACEUTICALS CO·Filed 2004·Application pending·0 cites
- 3143US2020016150A1Treatment of the pruritic symptoms of liver diseaseTREVI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3242US2018008592A1Treatment of uremic pruritusTREVI THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3338US2017216277A1Therapeutic use of nalbuphine without aquaretic effectsTREVI THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Sciascia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →